Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 478.78% and ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no signs of slowing down, much to the delight of its Danish manufacturer, Novo ...

Surgeons are collaborating with obesity medicine physicians, turning to GLP-1s to help high BMI patients qualify for surgery.

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic.

Polyneuropathy Treatment Market Benefiting from Innovations in Neuromodulation Techniques and High Focus on Pain ManagementRockville, MD , Jan. 07, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a ...

If adopted as currently written, House Bill 1114 would set out-of-pocket costs for a monthly supply of insulin at $25 for the ...

North Dakota lawmakers on Thursday will hear testimony on a bill to lower the price of insulin drugs and supplies for residents.

In this first weekly piece of the year, we will look at the "dogs" of the ASX from 2024, see how 2023 Dogs performed and mark ...

Jae Oh, author of "Maximize Your Medicare," echoed this advice: "If you plan to leave Medicare Advantage and return to original Medicare, securing acceptance for a Medigap plan should be your first ...

Eli Lilly and Company will attend the 43rd Annual J.P. Morgan Healthcare Conference, Jan. 13-16, 2025. David A. Ricks, Lilly chair and CEO, will participate in a fireside chat on Tuesday, Jan. 14 at 5 ...

Ozempic, Wegovy and Mounjaro featured prominently. Known for their use in managing type 2 diabetes and aiding weight loss for ...